Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

Related Posts

President Prabowo Inaugurates Pegadaian Gold Bank Service, BRI Group Optimistic in Strengthening the National Economy

President Prabowo Inaugurates Pegadaian Gold Bank Servi...

‘She’s not working outside the home’: My mother, 63, inherited $100,000. Is she too old to invest in the stock market?

‘She’s not working outside the home’: My mother, 63, in...

Virgin Galactic’s new spacecraft looms large as company eyes future profitability

Virgin Galactic’s new spacecraft looms large as company...

South Korea's pension fund logs record 15% investment return in 2024

South Korea's pension fund logs record 15% investment r...

SS&C Technologies director Michael Zamkow sells $2.03 million in stock

SS&C Technologies director Michael Zamkow sells $2.03 m...

Canada watchdog probing X's use of personal data in AI models' training

Canada watchdog probing X's use of personal data in AI ...